Boisjoly H M, Tourigny R, Bazin R, Laughrea P A, Dubé I, Chamberland G, Bernier J, Roy R
Ophthalmology Research Unit, Centre Hospitalier de l'Université Laval Research Center, Laval University School of Medicine, Québec City, Canada.
Ophthalmology. 1993 Nov;100(11):1728-35. doi: 10.1016/s0161-6420(93)31409-0.
To measure the association between potential risk factors and corneal graft failure. Two failure outcomes are compared: those with and those without a prior immune allograft reaction.
Based on a single-center observational study design, 539 adult recipients of a corneal graft were followed for a median time of 30 months. Survival analysis was carried out.
Eighty-two graft failures were recorded. Of 82 failures, 53 (65%) were not preceded by an immune allograft reaction. Presence of blood vessels in the recipient cornea was associated with a twofold increase in risk for both failure outcomes. Three factors increased the risk of failure without an immune reaction: prior glaucoma or uveitis (adjusted relative risk estimate = 3.1), vitreous surgery with the graft (adjusted relative risk estimate = 2.0), and a repeat graft in the study eye (adjusted relative risk estimate = 2.0). Conversely, large graft wound size (adjusted relative risk estimate = 2.0). Conversely, large graft wound size (adjusted relative risk estimate = 2.9) and human leukocyte antigen (HLA)-A, -B incompatibility (adjusted relative risk estimate = 2.2) were associated with failures that followed an immune reaction.
In this study, the authors support the clinical impression that corneal graft failures with and without a prior immune reaction are distinct phenomena. Enhanced surveillance in recipients with glaucoma and early intensive treatment of allograft reactions are recommended to improve the outcome of corneal grafts.
测量潜在风险因素与角膜移植失败之间的关联。比较两种失败结局:有和没有先前免疫同种异体移植反应的情况。
基于单中心观察性研究设计,对539例成年角膜移植受者进行了为期30个月的中位随访。进行了生存分析。
记录了82例移植失败。在82例失败中,53例(65%)之前没有免疫同种异体移植反应。受者角膜中血管的存在与两种失败结局的风险增加两倍相关。三个因素增加了无免疫反应时的失败风险:先前的青光眼或葡萄膜炎(调整后的相对风险估计值 = 3.1)、与移植同时进行的玻璃体手术(调整后的相对风险估计值 = 2.0)以及研究眼中的再次移植(调整后的相对风险估计值 = 2.0)。相反,较大的移植伤口大小(调整后的相对风险估计值 = 2.0)。相反,较大的移植伤口大小(调整后的相对风险估计值 = 2.9)和人类白细胞抗原(HLA)-A、-B不相容性(调整后的相对风险估计值 = 2.2)与免疫反应后的失败相关。
在本研究中,作者支持临床印象,即有和没有先前免疫反应的角膜移植失败是不同的现象。建议加强对青光眼患者的监测并对同种异体移植反应进行早期强化治疗,以改善角膜移植的结局。